Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Alexion Pharmaceuticals Inc.
DescriptionLong-acting humanized mAb against complement 5 (C5)
Molecular Target Complement 5 (C5)
Mechanism of ActionComplement inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I/II
Standard IndicationParoxysmal nocturnal hemoglobinuria (PNH)
Indication DetailsTreat paroxysmal nocturnal hemoglobinuria (PNH)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today